Notice of NIDDK Participation in (RFA-OD-22-010) Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Notice Number:
NOT-DK-24-019

Key Dates

Release Date:

March 26, 2024

Related Announcements

  • April 05, 2022- Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required). See NOFO RFA-OD-22-010. 

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice informs potential applications of the National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) participation, effective immediately, in the notice of funding opportunity RFA-OD-22-010 “Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required.”

The following sections of RFA-OD-22-010 have been modified to reflect the NIDDK's participation in this NOFO:

Components of Participating Organizations:

Currently reads:

Office of The Director, National Institutes of Health (OD)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Cancer Institute (NCI)

 Modified to Read (changes shown in bold italics):

Office of The Director, National Institutes of Health (OD)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Cancer Institute (NCI)
National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK)

Assistance Listing Number(s):

Currently reads:

93.865, 93.173, 93.866, 93.846, 93.855, 93.242, 93.867, 93.351, 93.838, 93.837, 93.839, 93.840, 93.233, 93.396, 93.853, 93.393, 93.121, 93.172

Assistance Listing Number(s):

Modified to read (changes shown in bold italics):

93.865, 93.173, 93.866, 93.846, 93.855, 93.242, 93.867, 93.351, 93.838, 93.837, 93.839, 93.840, 93.233, 93.396, 93.853, 93.393, 93.121, 93.172, 93.847

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Robert Rivers, Ph.D.
National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK)
Phone: 301-443-8415
Email: robert.rivers@nih.gov